-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Haemonetics, Raises Price Target to $92

Benzinga·08/07/2026 20:53:46
Listen to the news
Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $79 to $92.